Use of an Occlusal Support Device During the Second Stage of Labor

Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT02807493
Collaborator
(none)
347
1
2
47.8
7.3

Study Details

Study Description

Brief Summary

The primary objectives of this study are to determine if the use of an Occlusal Support Device (OSD)(Mouthguard) can reduce the duration and intensity of the second stage of labor, reduce the incidence of labor complications including Caesarian Sections and improve Apgar scores in newborns

Condition or Disease Intervention/Treatment Phase
  • Device: Occlusal Support Device
  • Other: Control
N/A

Detailed Description

Prolonged labor, especially during the second stage of active expulsive effort (the pushing phase), is associated with increased risk of maternal complications (e.g. tissue trauma, postpartum hemorrhage, intra-amniotic infection). Developing an effective method to assist and maximize maternal expulsion effort should be of great value in reducing the number of complications, also including cesarean section or instrumental deliveries. Past studies published in the dental literature have shown that specially designed oral appliances that support the dental occlusion may increase the isometric strength of different muscle groups. Increased strength of the neck muscles could improve efficiency of the Valsalva maneuver in increasing intra-uterine pressure, and thus decreasing the duration of phase II of labor. Nulliparous women with uncomplicated singleton pregnancy will be randomly assigned to either the study group (Dental appliance) or the no dental appliance group. Duration of labor will be measured for both phase I and phase II. Rates for cesarean section and instrument deliveries and other complications will be charted as well as Apgar scores .

Study Design

Study Type:
Interventional
Actual Enrollment :
347 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Use of an Occlusal Support Device During the Second Stage of Labor
Actual Study Start Date :
Apr 1, 2017
Actual Primary Completion Date :
Mar 26, 2021
Actual Study Completion Date :
Mar 26, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Occlusal Support Device

Support device for women in labor

Device: Occlusal Support Device
Bite plate

Placebo Comparator: Control

No device given for women in labor

Other: Control
Control group

Outcome Measures

Primary Outcome Measures

  1. Number of complications [Baseline]

    Determine if an Occlusal Support Device (OSD) can reduce the duration and intensity of the second stage of labor

  2. Number of cesarians [Baseline]

    Determine if an OSD can reduce the incidence of labor complications including Caesarian Sections

  3. Difference in APGAR score [Baseline]

    Determine if the use of an OSD can improve Apgar scores in newborns.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Nulliparous women

  • Uncomplicated pregnancy

  • Singleton pregnancy

Exclusion Criteria:
  • Unable to provide informed consent or comply with study protocol,

  • High risk and/or complicated pregnancy,

  • Have multiple fetuses as diagnosed by ultrasound,

  • Have extensive decay or multiple broken/missing teeth that will interfere with the fabrication of an OSD

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: James E Gambucci, DDS, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT02807493
Other Study ID Numbers:
  • DENT-2016-23918
First Posted:
Jun 21, 2016
Last Update Posted:
Dec 28, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by University of Minnesota
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 28, 2021